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Background—There are few published data on the incidence of fatal and nonfatal stroke in American Indians. The aims of this
observational study were to determine the incidence of stroke and to elucidate stroke risk factors among American Indians.
Methods and Results—This report is based on 4549 participants aged 45 to 74 years at enrollment in the Strong Heart
Study, the largest longitudinal, population-based study of cardiovascular disease and its risk factors in a diverse group
of American Indians. At baseline examination in 1989 to 1992, 42 participants (age- and sex-adjusted prevalence
proportion 1132/100 000, adjusted to the age and sex distribution of the US adult population in 1990) had prevalent
stroke. Through December 2004, 306 (6.8%) of 4507 participants without prior stroke suffered a first stroke at a mean
age of 66.5 years. The age- and sex-adjusted incidence was 679/100 000 person-years. Nonhemorrhagic cerebral
infarction occurred in 86% of participants with incident strokes; 14% had hemorrhagic stroke. The overall age-adjusted
30-day case-fatality rate from first stroke was 18%, with a 1-year case-fatality rate of 32%. Age, diastolic blood pressure,
fasting glucose, hemoglobin A1c, smoking, albuminuria, hypertension, prehypertension, and diabetes mellitus were risk
factors for incident stroke.
Conclusions—Compared with US white and black populations, American Indians have a higher incidence of stroke. The
case-fatality rate for first stroke is also higher in American Indians than in the US white or black population in the same
age range. Our findings suggest that blood pressure and glucose control and smoking avoidance may be important
avenues for stroke prevention in this population. (Circulation. 2008;118:1577-1584.)
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Although cardiovascular disease is the leading cause ofdeath among American Indians,1 no cohort study has
examined the prevalence, incidence, and risk factors for stroke in
this population. Available data on incidence of nonfatal or fatal
stroke in American Indians come from a hospital case study2 and
from national survey data with a small number of American
Indian participants.3 Stroke mortality in American Indians has
been described in several reports by use of regional or
national death certificate data, which may misclassify race, as
well as the causes of death.4–7 To the best of our knowledge,
there are no studies of stroke incidence, risk factors, and case
mortality in a prospectively followed cohort of American
Indians with accurate measurement of baseline biological
parameters. Understanding the morbidity, mortality, and risk
factors of stroke in American Indians is important so that
appropriate prevention interventions can be implemented.
The present study was undertaken to determine stroke inci-
dence among American Indians 45 to 74 years of age and to
assess risk factors for incident stroke in this population.
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Methods
Study Population
The Strong Heart Study is a population-based cohort study of
cardiovascular disease and its risk factors in 13 American Indian
tribes/communities in southwestern Oklahoma, central Arizona, and
North and South Dakota. Participants (n4549; 2703 women) 45 to
74 years old underwent baseline examination from 1989 to 1992.
The design, survey methods, and laboratory techniques have been
described previously.8 –10 Participants in the present analysis
(n4507) had no history of stroke at the baseline examination.
Among them, 306 participants had an incident stroke during a mean
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follow-up of 13.4 years by the end of 2004. The first and third
quartiles of follow-up time were 9.2 and 14.4 years, respectively.
The Indian Health Service Institutional Review Board, institutional
review boards of the participating institutions, and participating
tribes approved the study. Informed consent was obtained from all
participants.
Baseline Evaluation
Information on demographic factors, medical history, medication
use, and personal health habits (physical activity, smoking, and
alcohol consumption) was collected by personal interview. A phys-
ical examination was conducted, and fasting blood samples were
collected for laboratory tests, including lipids, lipoproteins, and a
75-g oral glucose tolerance test. Anthropometric measurements were
performed, and sitting blood pressure (first and fifth Korotkoff
sounds) was measured 3 times consecutively with mercury sphyg-
momanometers (WA Baum Co, Copiague, NY) after 5 minutes of
rest.11 The averages of the second and third systolic and diastolic
blood pressure measurements were used in the analysis.
Hypertension was defined by the criteria of the seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of Hypertension (JNC-7; systolic blood pressure
140 mm Hg, diastolic blood pressure 90 mm Hg, or use of antihy-
pertensive medication).12 Prehypertension was defined as systolic blood
pressure 120 to 139 mm Hg or diastolic blood pressure 80 to 89 mm Hg.
Normal blood pressure was defined as 120/80 mm Hg.
Diabetes was defined by the 1998 Provisional World Health
Organization Report13 (fasting glucose 7.0 mmol/L [126 mg/dL] or
post–75-g oral glucose challenge blood glucose of 11.1 mmol/L
[200 mg/dL], or use of an oral hypoglycemic agent or insulin). Impaired
glucose tolerance was defined as fasting glucose 7.0 mmol/L with
postchallenge glucose between 7.8 and 11.09 mmol/L (140 to 199.9
mg/dL). Impaired fasting glucose was defined as fasting glucose
between 6.1 and 6.9 mmol/L (110 to 125.9 mg/dL) with postchallenge
glucose 7.8 mmol/L. Impaired glucose tolerance and impaired
fasting glucose were combined as 1 category designated as “impaired
glucose metabolism.” Normal glucose tolerance was defined as
fasting glucose 6.1 mmol/L with postchallenge glucose
7.8 mmol/L. Fasting insulin in serum or plasma was measured by
radioimmunoassay according to established methods.14
Microalbuminuria and macroalbuminuria were defined as urinary
albumin/creatinine ratios of 30 to 299 mg/g and 300 mg/g,
respectively. Past smoking was defined as having smoked at least
100 cigarettes in the subject’s entire life, having smoked cigarettes
regularly in the past, and not smoking currently. Current smoking
was defined as having smoked at least 100 cigarettes in the subject’s
entire life, having smoked cigarettes regularly, and smoking cur-
rently. Past alcohol users were defined as those who had consumed
at least 12 drinks of any kind of alcoholic beverage in their entire life
and who drank their last drink at least 1 year ago. Current alcohol
users were defined as those who consumed at least 12 drinks of any
kind of alcoholic beverage in their entire life and who were drinking
currently. Information on leisure-time and occupation-related phys-
ical activities was collected with a physical activity questionnaire.
This questionnaire has been validated in Pima Indians and other
populations. An estimate of the individual’s self-reported physical
activity level was averaged over the past year and expressed as hours
per week.15,16
Outcome Variables
Incident strokes included fatal and nonfatal events that occurred
between the baseline examination and December 31, 2004, in
participants without a prior history of stroke.
Fatal Stroke
Fatal events included definite and possible fatal strokes. Deaths that
occurred between the baseline examination and December 31, 2004,
were confirmed through Indian Health Service or private hospital
records and through direct contact by study personnel with partici-
pants’ families or other informants.1,8,9,17 The process of ascertaining
stroke deaths has been reported previously.1 Physician members of
the Strong Heart Study Mortality Committee reviewed all medical
records, information obtained from informants and death certificates,
and coroner’s or medical examiner’s reports when available. Two
reviewers reviewed each chart, and if there was lack of agreement,
the chart was then reviewed by the entire adjudication committee. If
reviewers found the death was stroke related, the case was sent to
neurologists (D.O.W., J.P.W.) for confirmation with previously
described criteria17 that differentiated cardioembolic, lacunar, and
other thrombotic cerebral infarctions; intraparenchymal (intracere-
bral) hemorrhage; subarachnoid hemorrhage; and stroke of unknown
type. Mortality follow-up data were available in 99.8% of the
participants.
Nonfatal Stroke
The process to confirm nonfatal stroke was similar to that for fatal
stroke. Neurologists (D.O.W., J.P.W.) made up the adjudication
review committee and provided the final diagnosis for nonfatal
events (definite and possible nonfatal strokes) that occurred from the
baseline examination to the end of 2004 and for prevalent strokes
that occurred before the baseline examination.1,8,17,18 Stroke sub-
types used were the same as described for fatal stroke. Transient
ischemic attack was not included in the analysis. If more than 1 event
occurred in the same individual, the date of the earliest event was
considered the first stroke date.
Statistical Analysis
Person-time incidence rates of stroke were calculated in male,
female, and both male and female participants for 3 study centers.
Age-specific rates and age-adjusted rates, age- and sex-adjusted
rates, and their 95% CIs were calculated. The US 1990 population
was used as the standard population in all age-adjustments.
Overall and age-specific proportions of stroke subtypes among all
strokes were provided. The proportion of persons with a history of
stroke at baseline was calculated for males, females, and all
participants for 3 centers. Age-specific, age-adjusted, and age- and
sex-adjusted proportions and their 95% CIs were also calculated.
Age-adjusted 30-day and 1-year mortality rates and their 95% CIs
for first stroke were calculated for both genders. Mean age at onset
of first stroke was calculated for all incident stroke cases and cerebral
infarction cases for 1989 to 2004 in both genders and 3 study centers.
Baseline characteristics including age, sex, body mass index, waist
circumference, systolic and diastolic blood pressure, and LDL and
HDL cholesterol are presented as means (SDs) for participants with
or without incident stroke. The t test was used to compare means
between 2 groups. Triglycerides, fasting glucose, 2-hour glucose,
hemoglobin A1c (HbA1c), insulin, and physical activity are presented in
quartiles (first quartile, median, third quartile). A nonparametric rank
sum test19 was used to compare the distribution of these variables
between groups because of their skewed distributions. Proportions of
women, prehypertension, hypertension, diabetes, macroalbuminuria,
microalbuminuria, smoking, and alcohol use are presented in partic-
ipants with and without incident stroke and were compared between
groups by the 2 test. Two-tailed P0.05 was considered to be
statistically significant.
The incidence of stroke was also calculated according to different
categories of risk factors, including blood pressure, HDL and LDL
cholesterol levels, diabetes, fasting glucose, HbA1c, smoking, and
albuminuria. The log-rank test was used to compare the incidence of
stroke among the categories. The calculation of incidence and the
log-rank test were adjusted for age and sex.
Cox proportional hazard models were used to assess association of
stroke with its potential risk factors, including age, gender, systolic
and diastolic blood pressures, body mass index, waist circumference,
LDL and HDL cholesterol, triglycerides, physical activity, smoking,
alcohol use, microalbuminuria, and macroalbuminuria. Hypertension
and prehypertension were entered in alternative models as categor-
ical variables instead of systolic and diastolic blood pressure. All
other covariates remained the same. Additional models considered
HbA1c or diabetes instead of fasting glucose; all other covariates
remained the same. The multivariable analyses were done separately
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for all strokes and cerebral infarctions but not for hemorrhagic stroke
because of the limited number of incident cases (n37).
The authors had full access to the data and take full responsibility for its
integrity. All authors have read and agree to the manuscript as written.
Results
Prior Stroke
Among the 4549 participants at baseline, 42 had a history of
stroke. The age- and sex-adjusted prevalence proportion was
1132/100 000. The prevalences for age groups of 45 to 54
years, 55 to 64 years, and 65 to 74 years were 450, 1130, and
1870 per 100 000, respectively. Age-adjusted prevalences for
men and women were 1625 and 695 per 100 000, respec-
tively. Age- and sex-adjusted prevalence for Arizona, Okla-
homa, and South and North Dakota did not differ signifi-
cantly and was 741/100 000 (10 cases, 95% CI 0 to 1511.9),
1352 (18 cases, 95% CI 0 to 2754.6), and 1193 (14 cases,
95% CI 0 to 3091.9), respectively.
Incidence Rate of Stroke
From 1989 to 2004, 306 incident strokes occurred among Strong
Heart Study participants without a prior stroke, an age- and sex-
adjusted incidence of 679/100 000 person-years (Table 1). The
incidence increased with older age in both men and women in all
3 centers. The age-adjusted incidences for men and women were
707/100 000 and 653/100 000 person-years, respectively.
Stroke Subtypes
Cerebral infarctions were by far the predominant subtype of
stroke, constituting 86% of incident stroke cases; 14% of
subjects had hemorrhagic stroke, mostly intraparenchymal
(Table 2). Intraparenchymal hemorrhages were more com-
mon in the youngest age group (45-to-54-year-olds).
Age of Occurrence of First Stroke
The mean age of occurrence of first stroke for all strokes and for
cerebral infarction was 66.5 years. Arizona participants with







TotalProportion, % No. Proportion, % No. Proportion, % No.
45–54 82 73 15.7 14 2.2 2 89
55–64 87.3 89 10.8 11 2 2 102
65–74 88.1 59 7.5 5 4.5 3 67
Total 85.7 221 11.6 30 2.7 7 258
Table 1. Age- and Sex-Specific Incidence Rates of Stroke per 100 000 Person-Years (1989–2004)









Cohort‡Rate No. Rate No. Rate No. Rate No.
Male
45–54 472 16 280 11 284 11 340 61 9 N/A N/A
55–64 960 14 872 19 938 23 920 363 39 N/A 433
65–74 687 5 1138 13 1113 10 1011 885 62 N/A 1112
Total 627 35 594 43 609 44 609 N/A
AAR (95% CI) 689 (55–1324) 701 (0–1806) 717 (0–1829) 707 (0–1641)
Female
45–54 452 27 321 16 463 24 415 64 10 N/A N/A
55–64 653 23 594 23 604 20 617 195 24 N/A 218
65–74 777 12 1035 21 1166 18 997 524 55 N/A 697
Total 561 62 551 60 618 62 576
AAR (95% CI) 614 (202–1025) 622 (0–1509) 718 (0–1621) 653 (0–1378)
Males and females
45–54 459 43 303 27 387 35 384 63 19 320 135
55–64 743 37 694 42 746 43 727 273 63 637 323
65–74 748 17 1072 34 1146 28 1002 669 117 972 879
Total 584 97 568 103 614 106 588
ASAR 649 (445–854) 659 (280–1038) 718 (337–1098) 679 (364–994)
AAR indicates age-adjusted rate; ASAR, age- and sex-adjusted rate.
*In Rochester, Minn, 1985–1989.
†The Greater Cincinnati/Northern Kentucky Stroke Study, 1993.
‡Framingham Heart Study 1980-2003.
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strokes were younger than Oklahoma participants with strokes
(mean 65 versus 68 years old, respectively; P0.048). The mean
age of Dakota participants with strokes (66.4 years) did not
differ from Oklahoma or Arizona. The average age of stroke
onset was similar in men (66.2 years) and women (66.7 years;
P0.60).
Survival
Overall 30-day case fatality from first stroke was 18%, with
a 1-year case-fatality rate of 32% (Table 3). Although the
30-day and 1-year case-fatality rates for men and women did
not differ, fatality rates were higher in Arizona than in the
other 2 centers.
Characteristics of Participants With or Without
Incident Stroke
Participants with incident stroke were older; had higher systolic
and diastolic blood pressures, triglycerides, fasting glucose,
HbA1c, insulin, and 2-hour glucose levels; had lower HDL
cholesterol levels; and were less physically active at baseline
than participants who remained stroke-free (Table 4). Hyperten-
sion, diabetes, microalbuminuria, and macroalbuminuria were
Table 3. Age-Adjusted 30-Day and 1-Year Mortality From First Stroke (1989–2004)
Time Point and Category
Arizona Oklahoma South/North Dakota
Mortality, % No. Mortality, % No. Mortality, % No. Total, %
30 Days
Male 23.3 (15–30)* 8 16.1 (10–23) 7 16.2 (10–23) 7 18 (11–25)
Female 32 (25–38) 19 9.8 (5–14) 7 13.2 (8–18) 8 18.5 (13–24)
Malefemale 29.1 (24–34) 27 12.4 (9–16) 14 14.7 (10–18) 15 18.3 (14-23)
1 Year
Male 39.3 (30–47) 13 31.6 (23–40) 14 23.4 (16–31) 10 31 (23–39)
Female 44.7 (37–52) 26 21.5 (16–28) 14 30.9 (24–38) 18 33.1 (26–40)
Malefemale 42.7 (37–48) 39 25.7 (21–31) 28 28 (23–33) 28 32.2 (27–38)
*95% confidence interval.
Table 4. Comparison of Baseline Characteristics of the Strong Heart Study Participants With and
Without Incident Stroke
Variables Without Stroke (n4201) With Incident Stroke (n306) P
Age, y 56.1 (8.0) 59.3 (8.1) 0.001
Female, % 59.5 60 0.8
Body mass index, kg/m2 30.9 (6.4) 30.6 (5.3) 0.4
Waist circumference, cm 105.1 (14.7) 105.8 (13.3) 0.4
Systolic blood pressure, mm Hg 127.2 (19.6) 134.9 (20.2) 0.001
Diastolic blood pressure, mm Hg 76.6 (10.1) 78.5 (10.8) 0.002
LDL cholesterol, mmol/L 3.0 (0.9) 3.0 (0.9) 0.6
HDL cholesterol, mmol/L 1.2 (0.3) 1.1 (0.3) 0.005
Triglycerides, mmol/L 1.3 (0.9, 1.9) 1.5 (1.1, 2.2) 0.001
Fasting glucose, mmol/L 6.3 (5.5, 9.4) 8.2 (5.9, 13.3) 0.001
Two-hour glucose, mmol/L 7.8 (6.0, 11.5) 8.9 (6.2, 15.2) 0.02
Hemoglobin A1c, % 5.6 (5.0, 7.9) 6.7 (5.5, 10.2) 0.001
Insulin, pmol/L 96.2 (56.9, 155.4) 106.8 (67.8, 157.8) 0.03
Prehypertension, % 32.4 30.2 0.4
Hypertension, % 38 55.7 0.001
Diabetes, % 47.3 69 0.001
Microalbuminuria, % 18.4 27.1 0.001
Macroalbuminuria, % 9.7 22.7 0.001
Physical activity, h/wk 10 (1.8, 27.7) 6.9 (0.7, 24.6) 0.04
Current smoking, % 33.7 36.6 0.3
Past smoking, % 33.6 35.6 0.5
Current alcohol use, % 42.4 31.7 0.001
Past alcohol use, % 41.5 50 0.003
Values in parentheses are SDs (when mean values are presented) or first and third quartiles (when median values are
presented).
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significantly more prevalent at baseline among participants with
subsequent stroke, and those with incident stroke were more
likely at baseline to be past alcohol users but less likely to be
current alcohol users than those who remained stroke-free.
Risk Factors for Stroke
Participants with elevated baseline levels of blood pressure,
fasting glucose, HbA1c, and albuminuria had significantly
higher incidence of stroke than those with normal levels
(Table 5). Participants with lower levels of HDL cholesterol
had significantly higher stroke incidence than those with
higher levels. Baseline LDL cholesterol levels were not
significantly related to stroke incidence, nor were those of
non-HDL cholesterol (data not shown). Current smokers had
significantly higher stroke incidence than past smokers and
nonsmokers, as did participants with hypertension, prehyper-
tension, diabetes, and impaired glucose compared with those
who did not have those conditions.
In a Cox proportional hazard model for all strokes (Table
6), age, diastolic blood pressure, fasting glucose, smoking,
and albuminuria were risk factors for stroke incidence.
Current and past smokers had 2.4- and 1.6-fold higher risks of
incident stroke, respectively, than never-smokers. Macroal-
buminuria, and microalbuminuria increased the risk 3.3 and
1.7 times, respectively. When hypertension and prehyperten-
sion were put in the model instead of systolic and diastolic
blood pressures, the risks of incident stroke were 2.2 and 1.8
times higher than in normotensive participants. When HbA1c
was put in the model instead of fasting glucose, each percent
increase of HbA1c was associated with a 1.15-fold higher risk
of incident stroke. When diabetes and impaired glucose
metabolism were put in the model instead of fasting glucose,
they increased the risk of incident stroke by 2.1- and 1.2-fold,
although the effect of impaired glucose metabolism was not
statistically significant. The results of the multivariable model
for cerebral infarction only (data not shown) are similar to the
results for all strokes. Although insulin levels were associated
with incident stroke in univariable analyses, the association
was not significant after adjustment for other covariates.
Discussion
The present report provides the first detailed information on
stroke incidence rates and risk factors in American Indians
Table 5. Stroke Incidence (per 100 000 Person-Years)







Normal 1283 43 19 041 301
Prehypertension 1449 92 15 563 539




120 1641 66 19 825 361
120–139 1808 127 21 097 610
140–159 744 77 8136 756




80 2765 169 31 939 513
80–89 1281 97 14 955 711
90–99 354 28 4020 769
100 85 10 882 1540
P * 0.001
HDL cholesterol, mmol/L
1.0 (40 mg/dL) 1544 126 17 693 750
1.0–1.54 (40–59 mg/dL) 2262 143 26 690 537
1.55 (60 mg/dL) 606 28 6918 429
P * 0.001
LDL cholesterol, mmol/L
2.59 (100 mg/dL) 1346 92 14 993 617
2.59–3.35 (100–129 mg/dL) 1528 100 18 079 555
3.36–4.13 (130–159 mg/dL) 965 59 11 545 518
4.14–4.8 (160–189 mg/dL) 315 26 3794 705
4.9 (190 mg/dL) 115 8 1323 700
P * 0.94
Diabetes (WHO 1998 criteria)
Normal 1332 50 16 334 312
Impaired glucose
metabolism
891 43 11 112 393
Diabetes 2196 211 23 536 887
P * 0.001
Fasting glucose, mmol/L
6.1 (110 mg/dL) 1873 81 22 691 367
6.1–6.9 (110–125 mg/dL) 679 40 8377 445
7.0 (126 mg/dL) 1783 172 19 387 889
P * 0.001
HbA1c, %
5 984 34 11 461 330
5–7 1899 115 23 282 471










Current 1527 112 17 168 709
Past 1516 109 17 468 514
Never 1457 85 17 318 491
P * 0.004
Albuminuria
Normal 3084 148 38 014 395
Microalbuminuria 831 80 9074 885
Macroalbuminuria 464 67 3907 1708
P * 0.001
*P value from log-rank test for comparison of survival curves among
categories of the variables.
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derived from a large, prospectively followed population-
based sample with a broad collection of risk factors and
thorough morbidity and mortality surveillance.
Incidence
Compared with other populations of similar age followed up
over a similar time period with similar diagnostic methods,
the present report documents higher overall stroke incidence
in American Indians than in either US whites20,21 or blacks.22
Incidence rates for stroke were higher in both sexes compared
with whites,20,21 but sex-specific data comparable to the
present study were not available for blacks. We also could not
find comparable data for a broad sample of the US Hispanic
population, although 1 study reports a stroke incidence for
Hispanics that is lower than for blacks but higher than for
whites.23
Stroke Subtypes
Data pooled from the Atherosclerosis Risk in Communities
Study, the Cardiovascular Health Study, and the Framingham
Heart Study indicated that ischemic and hemorrhagic strokes
account for 87% and 13% of all strokes, respectively,24
almost identical to the proportions of subtypes of first stroke
in the Strong Heart Study population. In younger age groups,
however, there was a higher proportion of hemorrhagic stroke
(mainly intraparenchymal hemorrhage) among American
Indians.
Case Fatality of First Stroke
Among American Indians, both the 30-day and 1-year case-
fatality rates after first stroke were higher in women than in
men, similar to national data.24 The pooled data from the
Framingham Heart Study, Atherosclerosis Risk in Commu-
nities Study, and Cardiovascular Health Study showed that
1-year case fatality after a first stroke was 21% for men and
24% for women whose age was 40 years.24 The 1-year
mortality in participants in the Strong Heart Study was almost
1.5 times these rates.24 We could not find comparable data in
other populations for 30-day case fatality.
Risk Factors for Stroke
From the Cox proportional hazard model, age, diastolic blood
pressure, fasting glucose, current and past smoking, microal-
buminuria and macroalbuminuria, hypertension, prehyperten-
sion, HbA1c, and diabetes were all risk factors for first stroke
in American Indians. Age has been reported as the strongest
nonmodifiable risk factor for stroke in several studies.25–27 In
American Indians, age was also a strong risk factor. Although
men have a higher risk of stroke than women in other
populations, sex was not a significant risk factor for stroke in
the present study population.28 The association between
diastolic blood pressure and stroke has been demonstrated in
both observational studies and clinical trials.29,30 Although a
clinical trial showed that active treatment of isolated systolic
hypertension lowered the incidence of stroke by 42%,31
systolic blood pressure was not a risk factor for incident
stroke, whereas diastolic blood pressure was a risk factor in
the Strong Heart Study population, which possibly was
related to the fact that 83% of participants in the Strong Heart
Study were 65 years old at enrollment. Hypertension and
prehypertension were related to incident stroke when treated
as categorical variables. Both current smoking and past
history of smoking were related to increased stroke risk in the
present study population, similar to several other studies.32–34
Diabetes predicted incident stroke in several studies, with
similar hazard ratios, possibly related to diabetic angiopathy
in cerebral blood vessels.25,35 Fasting glucose and HbA1c were
significant risk factors for stroke. Fasting glucose has been
shown to be a risk factor for stroke in people with or without
diabetes in several studies.36–38 The associations between
microalbuminuria and macroalbuminuria and stroke were
very strong, which probably reflects the widespread vascular
damage of endothelial dysfunction. Further studies of the
association between kidney function and stroke incidence are
needed.35,39,40
Table 6. Cox Proportional Hazards Model for All Strokes
Variables P Hazard Ratio (95% CI)*
Age, y 0.001 1.07 (1.05–1.09)
Gender (male vs female) 0.77 0.95 (0.71–1.28)
Systolic blood pressure (per
20 mm Hg)
0.2 1.10 (1.0–1.22)
Diastolic blood pressure (per
10 mm Hg)
0.02 1.21 (1.1–1.48)
Body mass index (kg/m2) 0.43 0.98 (0.94–1.03)
Waist circumference (cm) 0.95 1.00 (0.98–1.02)
LDL cholesterol, mmol/L 0.8 0.98 (0.85–1.14)
HDL-cholesterol, mmol/L 0.08 0.67 (0.43–1.05)
Triglyceride, mmol/L 0.9 0.99 (0.84–1.17)
Physical activity (h/wk) 0.68 1.00 (0.99–1.01)
Fasting glucose, mmol/L 0.001 1.07 (1.04–1.1)
Current smoking (vs never smoking) 0.001 2.38 (1.69–3.36)
Past smoking (vs never smoking) 0.006 1.6 (1.14–2.25)
Current alcohol users (vs
never-users)
0.23 0.78 (0.51–1.17)
Past alcohol users (vs never-users) 0.87 1.03 (0.7–1.48)
Microalbuminuria (vs normal) 0.001 1.73 (1.25–2.38)
Macroalbuminuria (vs normal) 0.001 3.3 (2.29–4.77)
Alternative models
Hypertension and prehypertension
(instead of systolic and diastolic
blood pressure)*




HbA1c (instead of fasting
glucose)*
HbA1c, % 0.001 1.15 (1.08–1.21)
Diabetes and impaired glucose
(instead of fasting glucose)*




(vs normal glucose tolerance)
0.49 1.17 (0.75–1.8)
*All other covariates remained the same.
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Because of the small number of prevalent cases, it was not
possible to compare stroke prevalence between the Strong
Heart Study cohort and other populations.20 We also could
not compare the age of onset for first stroke with other
populations20 because of the different baseline age range in
the Strong Heart Study population.
In summary, incidence and case-fatality rates of stroke in
American Indians were high compared with other segments
of the US population. Our findings confirm the strong
associations between hypertension, diabetes, and cigarette
smoking and risk of stroke. Each of these risk factors
provides important avenues for intervention to reduce risk.
The basis of the higher case fatality from stroke in this
population deserves further study.
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CLINICAL PERSPECTIVE
The incidence of stroke and its determinants have not been examined in a prospective and systematic fashion in the
American Indian population. In this population-based study of American Indians who underwent standardized clinical and
laboratory evaluation during the period 1989 to 1992 and regular follow-up through 2004, the rate of first stroke was
unusually high. After we accounted for differences in age and sex, stroke incidence exceeded that recorded in
community-based studies of white and, notably, black US populations, who have an especially high stroke rate. Moreover,
the 1-year case-fatality rate after stroke in American Indians surpassed those of other populations. As in previous
epidemiological studies, age, hypertension, diabetes mellitus, and smoking were independent predictors of stroke, as were
microalbuminuria, macroalbuminuria, and hyperglycemia. Diastolic but not systolic blood pressure independently
predicted stroke, which likely reflects a preponderance of participants 65 years of age. The independent relations of
hypertension, diabetes, smoking, and albuminuria (a marker of vascular damage and inflammation) with stroke indicate that
these factors heighten cerebrovascular risk in populations where they are prevalent. Clinicians may use this information to
advise patients how to reduce the risk of stroke by modifying their health behaviors or lifestyles and consequently improve
their risk factors. Amid the current worldwide epidemics of obesity and diabetes, the findings may also aid clinicians in
determining prevention strategies that target such risk factors.
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